Literature DB >> 10502537

Immunopathogenesis of environmentally induced lupus in mice.

V M Shaheen1, M Satoh, H B Richards, H Yoshida, M Shaw, J C Jennette, W H Reeves.   

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune syndrome defined by clinical and serologic features, including arthritis, glomerulonephritis, and certain autoantibodies such as anti-nuclear ribonucleoprotein (nRNP)/Smith antigen (Sm), DNA, and ribosomal P. Although lupus is considered primarily a genetic disorder, we recently demonstrated the induction of a syndrome strikingly similar to spontaneous lupus in many nonautoimmune strains of mice exposed to the isoprenoid alkane pristane (2,6,10,14-tetramethylpentadecane), a component of mineral oil. Intraperitoneal injection of pristane leads to the formation of lipogranulomas consisting of phagocytic cells that have engulfed the oil and collections of lymphocytes. Subsequently, pristane-treated BALB/c and SJL mice develop autoantibodies characteristic of SLE, including anti-nRNP/Sm, antiribosomal P, anti-Su, antichromatin, anti-single-stranded DNA, and anti-double-stranded DNA. This is accompanied by a severe glomerulonephritis with immune complex deposition, mesangial or mesangiocapillary proliferation, and proteinuria. All inbred mice examined appear to be susceptible to this novel form of chemically induced lupus. Pristane-induced lupus is the only inducible model of autoimmunity associated with the clinical syndrome as well as with the characteristic serologic abnormalities of SLE. Defining the immunopathogenesis of pristane-induced lupus in mice may provide insight into the causes of spontaneous (idiopathic) lupus and also may lead to information concerning possible risks associated with the ingestion or inhalation of mineral oil and exposure to hydrocarbons in the environment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502537      PMCID: PMC1566261          DOI: 10.1289/ehp.99107s5723

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  47 in total

Review 1.  The basis of autoimmunity: Part II. Genetic predisposition.

Authors:  A N Theofilopoulos
Journal:  Immunol Today       Date:  1995-03

Review 2.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

3.  Response of the peritoneal mesothelium to the mineral oil, pristane.

Authors:  L V Leak; M Potter; W J Mayfield
Journal:  Curr Top Microbiol Immunol       Date:  1985       Impact factor: 4.291

4.  Anti-fibrillarin autoantibodies in mercury-treated mice.

Authors:  P Hultman; S Eneström; K M Pollard; E M Tan
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

5.  Constitutive production of interleukin-6 and immunologic features in cardiac myxomas.

Authors:  M Jourdan; R Bataille; J Seguin; X G Zhang; P A Chaptal; B Klein
Journal:  Arthritis Rheum       Date:  1990-03

6.  Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.

Authors:  G Lattanzio; C Libert; M Aquilina; M Cappelletti; G Ciliberto; P Musiani; V Poli
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

7.  Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.

Authors:  M Satoh; A Kumar; Y S Kanwar; W H Reeves
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Theoretical analysis of in vivo macrophage adhesion and foreign body giant cell formation on polydimethylsiloxane, low density polyethylene, and polyetherurethanes.

Authors:  W J Kao; Q H Zhao; A Hiltner; J M Anderson
Journal:  J Biomed Mater Res       Date:  1994-01

9.  Pristane induces high titers of anti-Su and anti-nRNP/Sm autoantibodies in BALB/c mice. Quantitation by antigen capture ELISAs based on monospecific human autoimmune sera.

Authors:  M Satoh; E L Treadwell; W H Reeves
Journal:  J Immunol Methods       Date:  1995-05-11       Impact factor: 2.303

10.  A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18).

Authors:  D C Altieri; F R Agbanyo; J Plescia; M H Ginsberg; T S Edgington; E F Plow
Journal:  J Biol Chem       Date:  1990-07-25       Impact factor: 5.157

View more
  5 in total

Review 1.  FcgammaRII and multi-system autoimmune disease.

Authors:  Nicholas C van de Velde; Patricia L Mottram; P Mark Hogarth
Journal:  Springer Semin Immunopathol       Date:  2006-11-08

Review 2.  Role of Fc Receptors as a therapeutic target.

Authors:  Atsuhiro Masuda; Masaru Yoshida; Hideyuki Shiomi; Yoshinori Morita; Hiromu Kutsumi; Hideto Inokuchi; Shigeto Mizuno; Akira Nakamura; Toshiyuki Takai; Richard S Blumberg; Takeshi Azuma
Journal:  Inflamm Allergy Drug Targets       Date:  2009-03

3.  C1q Modulates the Response to TLR7 Stimulation by Pristane-Primed Macrophages: Implications for Pristane-Induced Lupus.

Authors:  Francesco Carlucci; Attia Ishaque; Guang Sheng Ling; Marta Szajna; Ann Sandison; Philippe Donatien; H Terence Cook; Marina Botto
Journal:  J Immunol       Date:  2016-01-15       Impact factor: 5.422

Review 4.  Lupus animal models and neuropsychiatric implications.

Authors:  Thaís Evelyn Karnopp; Gustavo Flores Chapacais; Eduarda Correa Freitas; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2020-11-06       Impact factor: 2.980

Review 5.  The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease.

Authors:  Mingxuan Chi; Kuai Ma; Jing Wang; Zhaolun Ding; Yunlong Li; Shaomi Zhu; Xin Liang; Qinxiu Zhang; Linjiang Song; Chi Liu
Journal:  J Immunol Res       Date:  2021-05-15       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.